IMMUNE CHECKPOINT INHIBITOR
Clinical trials for IMMUNE CHECKPOINT INHIBITOR explained in plain language.
Never miss a new study
Get alerted when new IMMUNE CHECKPOINT INHIBITOR trials appear
Sign up with your email to follow new studies for IMMUNE CHECKPOINT INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy could improve outcomes for advanced nasopharyngeal cancer
Disease control Recruiting nowThis study tests whether adding a new immunotherapy drug (cadonilimab) and low-dose radiation to standard chemotherapy can help people with advanced nasopharyngeal cancer live longer without the cancer coming back. About 380 adults aged 18-70 with newly diagnosed, advanced cancer…
Matched conditions: IMMUNE CHECKPOINT INHIBITOR
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 26, 2026 02:24 UTC
-
New combo therapy shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a special radiation method called lattice radiation therapy (LRT) combined with immunotherapy for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if this combination can shrink tumors and control the disease be…
Matched conditions: IMMUNE CHECKPOINT INHIBITOR
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 26, 2026 02:19 UTC
-
New combo therapy aims to stop liver cancer recurrence in high-risk patients
Disease control Recruiting nowThis study tests whether combining radiation therapy with an immunotherapy drug (sintilimab) is better than a standard liver-directed treatment (TACE) at preventing liver cancer from returning after surgery. It includes 286 adults whose tumors were removed but had narrow margins …
Matched conditions: IMMUNE CHECKPOINT INHIBITOR
Phase: PHASE3 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 26, 2026 02:13 UTC
-
New radiotherapy combo shows promise for tough kidney cancers
Disease control Recruiting nowThis study is testing a special type of radiotherapy for people with kidney cancer that got worse after immunotherapy. The goal is to see if this treatment can control the cancer and how safe it is. About 35 adults will take part, and their tumors will be checked regularly for up…
Matched conditions: IMMUNE CHECKPOINT INHIBITOR
Phase: PHASE2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Blood test may predict immunotherapy success in advanced cancers
Knowledge-focused Recruiting nowThis study is observing 50 adults with advanced cancers (lung, breast, colorectal, liver, stomach) who are starting immunotherapy. Researchers will track ctDNA levels in the blood to see if changes can predict early whether the treatment is working. They will also look at other m…
Matched conditions: IMMUNE CHECKPOINT INHIBITOR
Sponsor: Gene Solutions • Aim: Knowledge-focused
Last updated May 26, 2026 02:24 UTC